Creating light-controlled inhibitors for specific cellular signaling proteins
High throughput platform to engineer light-controlled inhibitors against guanine exchange factors of the Dbl family
This study is working on a new way to create light-controlled tools that can help scientists better understand how certain proteins, which are important for cell movement and immune responses, work in living cells.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Duke University NIH-funded |
| Lab location | 1 site (Durham, United States) |
| Project ID | NIH-10909046 on NIH RePORTER |
What this research studies
This research focuses on developing a high throughput platform to engineer inhibitors that can be controlled by light, targeting guanine exchange factors (GEFs) of the Dbl family. These GEFs play a crucial role in regulating cellular processes such as migration and immune responses. By using light to precisely control the activity of these proteins in living cells, the research aims to provide insights into their functions without the artifacts introduced by traditional methods. This innovative approach could enhance our understanding of complex cellular signaling networks.
Who could benefit from this research
Good fit: Ideal candidates for this research would be individuals with conditions related to abnormal cell migration or immune responses.
Not a fit: Patients with conditions unrelated to cellular signaling or those who do not exhibit issues with cell migration or immune activation may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic strategies for diseases where cellular signaling is disrupted.
How similar studies have performed: While the approach of using light-controlled inhibitors is innovative, similar methodologies have shown promise in other areas of cellular signaling research.
Where this research is happening
Durham, United States
- Duke University — Durham, United States (Active)
Researchers
- Principal investigator: Azoitei, Mihai Luchian — Duke University
- Study coordinator: Azoitei, Mihai Luchian
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.